Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Small for Gestational Age at Delivery: later-stage trial registry
2 of 3 indexed Small for Gestational Age at Delivery trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Small for Gestational Age at Delivery: 3 US clinical trials tracked, 2 recruiting.
Small for Gestational Age at Delivery is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Mirvie, running 1 of these trials.
Enrollment posture brief
Registry condition small-for-gestational-age-at-delivery
OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Small for Gestational Age at Delivery lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Small for Gestational Age at Delivery on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Small for Gestational Age at Delivery is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
NCT07221851
Growing Little PEAPODS Study
University of Wisconsin, Madison
NCT06226051
MIRACLE of LIFE Study
Mirvie
NCT06074601
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Small for Gestational Age at Delivery records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Small for Gestational Age at Delivery trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Small for Gestational Age at Delivery page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Small for Gestational Age at Delivery trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mirvie sponsors the most Small for Gestational Age at Delivery trials on record, review their full trial history before evaluating a specific study. See Mirvie's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Small for Gestational Age at Delivery condition card totals 3 registered trials; most-linked intervention Mirvie Predictive Test for Adverse Pregnancy Outcomes; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.